Announced
Completed
CONFLUENCE LIFE SCIENCES INC / ACLARIS THERAPEUTICS INC / Acquisition / Private / £15m
Synopsis
Sale of Confluence Life Sciences, a biotechnology company focused on the kinase inhibitors to treat inflammatory and immunological disorders and cancer, to Aclaris Therapeutics.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.